DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Pignata S, Scambia G, Katsaros D. et al.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol 2014;
15: 396-405
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.